Contribution of visceral adiposity and insulin resistance to metabolic risk factors in Japanese men

Metabolism: Clinical and Experimental

Volumn 59, Issue 5, 2010, Pages 748-754

  Oka, Rie ^a   Kobayashi, Junji ^b   Inazu, Akihiro ^c   Yagi, Kunimasa ^b   Miyamoto, Susumu ^a   Sakurai, Masaru ^d   Nakamura, Koshi ^d   Miura, Katsuyuki ^e   Nakagawa, Hideaki ^d   Yamagishi, Masakazu ^b  

^a Hokuriku Central Hospital   (Japan)

^b KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

^c KANAZAWA UNIVERSITY   (Japan)

^d KANAZAWA MEDICAL UNIVERSITY   (Japan)

^e SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ANTHROPOMETRY; ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIET RESTRICTION; GLUCOSE BLOOD LEVEL; HEALTH PROGRAM; HOMEOSTASIS; HUMAN; HYPERTENSION; HYPERTRIGLYCERIDEMIA; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; INTRAABDOMINAL FAT; JAPANESE; MAJOR CLINICAL STUDY; MALE; METABOLISM; PATIENT EDUCATION; PRIORITY JOURNAL; RISK FACTOR;

BLOOD GLUCOSE; BLOOD PRESSURE; CHOLESTEROL; CROSS-SECTIONAL STUDIES; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; INSULIN RESISTANCE; INTRA-ABDOMINAL FAT; JAPAN; LOGISTIC MODELS; MALE; MIDDLE AGED; TOMOGRAPHY, X-RAY COMPUTED; TRIGLYCERIDES;

EID: 77950608507     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2009.09.020     Document Type: Article

References (40)

1. Kahn R., Buse J., Ferrannini E., and Stern M. The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 28 (2005) 2289-2304
2. Kahn R. Metabolic syndrome: is it a syndrome? Does it matter?. Circulation 115 (2007) 1806-1810 [discussion 1811]
3. Reaven G.M. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 37 (1988) 1595-1607
4. Alberti K.G., Zimmet P., and Shaw J. Metabolic syndrome-a new world-wide definition. A consensus statement from the International Diabetes Federation. Diabet Med 23 (2006) 469-480
5. Ferrannini E., Haffner S.M., Mitchell B.D., and Stern M.P. Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome. Diabetologia 34 (1991) 416-422
6. Liese A.D., Mayer-Davis E.J., Tyroler H.A., et al. Development of the multiple metabolic syndrome in the ARIC cohort: joint contribution of insulin, BMI, and WHR. Atherosclerosis Risk in Communities. Ann Epidemiol 7 (1997) 407-416
7. Palaniappan L., Carnethon M.R., Wang Y., et al. Predictors of the incident metabolic syndrome in adults: the Insulin Resistance Atherosclerosis Study. Diabetes Care 27 (2004) 788-793
8. Maison P., Byrne C.D., Hales C.N., Day N.E., and Wareham N.J. Do different dimensions of the metabolic syndrome change together over time? Evidence supporting obesity as the central feature. Diabetes Care 24 (2001) 1758-1763
9. Wagenknecht L.E., Langefeld C.D., Scherzinger A.L., et al. Insulin sensitivity, insulin secretion, and abdominal fat: the Insulin Resistance Atherosclerosis Study (IRAS) Family Study. Diabetes 52 (2003) 2490-2496
10. Grundy S.M., Cleeman J.I., Daniels S.R., et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation 112 (2005) 2735-2752
11. Huxley R., James W.P., Barzi F., et al. Ethnic comparisons of the cross-sectional relationships between measures of body size with diabetes and hypertension. Obes Rev 9 Suppl 1 (2008) 53-61
12. Lear S.A., Humphries K.H., Kohli S., Chockalingam A., Frohlich J.J., and Birmingham C.L. Visceral adipose tissue accumulation differs according to ethnic background: results of the Multicultural Community Health Assessment Trial (M-CHAT). Am J Clin Nutr 86 (2007) 353-359
13. Kadowaki T., Sekikawa A., Murata K., et al. Japanese men have larger areas of visceral adipose tissue than Caucasian men in the same levels of waist circumference in a population-based study. Int J Obes (Lond) 30 (2006) 1163-1165
14. Nagaretani H., Nakamura T., Funahashi T., et al. Visceral fat is a major contributor for multiple risk factor clustering in Japanese men with impaired glucose tolerance. Diabetes Care 24 (2001) 2127-2133
15. Hayashi T., Boyko E.J., Leonetti D.L., et al. Visceral adiposity is an independent predictor of incident hypertension in Japanese Americans. Ann Intern Med 140 (2004) 992-1000
16. Despres J.P., Nadeau A., Tremblay A., et al. Role of deep abdominal fat in the association between regional adipose tissue distribution and glucose tolerance in obese women. Diabetes 38 (1989) 304-309
17. Fox C.S., Massaro J.M., Hoffmann U., et al. Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation 116 (2007) 39-48
18. Oka R., Miura K., Sakurai M., et al. Impacts of visceral adipose tissue and subcutaneous adipose tissue on metabolic risk factors in middle-aged Japanese. Obesity (Silver Spring) (2009)
19. Wallace T.M., Levy J.C., and Matthews D.R. Use and abuse of HOMA modeling. Diabetes Care 27 (2004) 1487-1495
20. Oka R., Miura K., Sakurai M., et al. Comparison of waist circumference with body mass index for predicting abdominal adipose tissue. Diabetes Res Clin Pract 83 (2009) 100-105
21. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., and Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (1985) 412-419
22. Kobayashi J., Tadokoro N., Watanabe M., and Shinomiya M. A novel method of measuring intra-abdominal fat volume using helical computed tomography. Int J Obes Relat Metab Disord 26 (2002) 398-402
23. Vega G.L., Adams-Huet B., Peshock R., Willett D., Shah B., and Grundy S.M. Influence of body fat content and distribution on variation in metabolic risk. J Clin Endocrinol Metab 91 (2006) 4459-4466
24. Kim K., Valentine R.J., Shin Y., and Gong K. Associations of visceral adiposity and exercise participation with C-reactive protein, insulin resistance, and endothelial dysfunction in Korean healthy adults. Metabolism 57 (2008) 1181-1189
25. Carr D.B., Utzschneider K.M., Hull R.L., et al. Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome. Diabetes 53 (2004) 2087-2094
26. Nieves D.J., Cnop M., Retzlaff B., et al. The atherogenic lipoprotein profile associated with obesity and insulin resistance is largely attributable to intra-abdominal fat. Diabetes 52 (2003) 172-179
27. Piche M.E., Weisnagel S.J., Corneau L., Nadeau A., Bergeron J., and Lemieux S. Contribution of abdominal visceral obesity and insulin resistance to the cardiovascular risk profile of postmenopausal women. Diabetes 54 (2005) 770-777
28. Julius U. Influence of plasma free fatty acids on lipoprotein synthesis and diabetic dyslipidemia. Exp Clin Endocrinol Diabetes 111 (2003) 246-250
29. Petersen K.F., Dufour S., Savage D.B., et al. The role of skeletal muscle insulin resistance in the pathogenesis of the metabolic syndrome. Proc Natl Acad Sci USA 104 (2007) 12587-12594
30. Faerch K., Borch-Johnsen K., Holst J.J., and Vaag A. Pathophysiology and aetiology of impaired fasting glycaemia and impaired glucose tolerance: does it matter for prevention and treatment of type 2 diabetes?. Diabetologia 52 (2009) 1714-1723
31. Miyazaki Y., Akasaka H., Ohnishi H., Saitoh S., DeFronzo R.A., and Shimamoto K. Differences in insulin action and secretion, plasma lipids and blood pressure levels between impaired fasting glucose and impaired glucose tolerance in Japanese subjects. Hypertens Res 31 (2008) 1357-1363
32. Haffner S.M., D'Agostino R., Saad M.F., et al. Increased insulin resistance and insulin secretion in nondiabetic African-Americans and Hispanics compared with non-Hispanic whites. The Insulin Resistance Atherosclerosis Study. Diabetes 45 (1996) 742-748
33. Guerrero R., Vega G.L., Grundy S.M., and Browning J.D. Ethnic differences in hepatic steatosis: an insulin resistance paradox?. Hepatology 49 (2009) 791-801
34. Jensen C.C., Cnop M., Hull R.L., Fujimoto W.Y., and Kahn S.E. Beta-cell function is a major contributor to oral glucose tolerance in high-risk relatives of four ethnic groups in the US. Diabetes 51 (2002) 2170-2178
35. Azuma K., Kadowaki T., Cetinel C., et al. Higher liver fat content among Japanese in Japan compared with non-Hispanic whites in the United States. Metabolism 58 (2009) 1200-1207
36. Abdul-Ghani M.A., Jenkinson C.P., Richardson D.K., Tripathy D., and DeFronzo R.A. Insulin secretion and action in subjects with impaired fasting glucose and impaired glucose tolerance: results from the Veterans Administration Genetic Epidemiology Study. Diabetes 55 (2006) 1430-1435
37. Donahue R.P., Bean J.A., Donahue R.D., Goldberg R.B., and Prineas R.J. Does insulin resistance unite the separate components of the insulin resistance syndrome? Evidence from the Miami Community Health Study. Arterioscler Thromb Vasc Biol 17 (1997) 2413-2417
38. Hanley A.J., Karter A.J., Festa A., et al. Factor analysis of metabolic syndrome using directly measured insulin sensitivity: the Insulin Resistance Atherosclerosis Study. Diabetes 51 (2002) 2642-2647
39. Phillips G.B., Jing T., and Heymsfield S.B. Does insulin resistance, visceral adiposity, or a sex hormone alteration underlie the metabolic syndrome? Studies in women. Metabolism 57 (2008) 838-844
40. Phillips G.B., Jing T., and Heymsfield S.B. Relationships in men of sex hormones, insulin, adiposity, and risk factors for myocardial infarction. Metabolism 52 (2003) 784-790